Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I've request their partner enablement pack.
Will share if it is received.
If this drops sub 90p plenty will buy in. Its got support there in the mid 90's.
They could say no sales yet, but it'll only tank if they announce pulling out of covid to concentrate of other stuff, thats never going to happen.
Every day the SP stays in the low 100's makes it less likely we will see losses recover. If i bought in at 100p for a punt, 150p is more than a good price to sell, and the issue may well be sustained selling all the way up to 200p from all those who got in early (if it ever goes that far). LTH's may not see their money, but new comers will most definitely see significant returns.
Reminds me of Tomco, decent SP pre placing last week, post placing it tanked as it normally would do, but since then its done 25-30% in a few days, but the LTH's have got shafted and the new comers are laughing.
samolly2, if there is bad news do you think the MM will be kind, of course not they will be taking advantage, 80p is not a certainty for a strong support level when you are on the AIM market with the MM and the games they play....
I hope GDR also let the share holders know soon just what they have done with the 8 million raised through there poorly timed placing that lost so much value for a lot of pi's.
I do find it odd they haven't updated anything at all since 22nd May. Why wouldn't you set out how you are,going about and achieving sales and keep the share price buoyant. I was in jubilant mode end of May so gave them the benefit of the doubt and did have too much concern of first sales. That now looks foolish as I am heavily down and now have all the risk of this falling further. Really pi55es me off to be honest. That at every other stock I'm watching has had way more green days than this. Learning a other lesson here.
LB28 - How nany weeks has it been since CE and how many sales have been confirmed... NON! that is all we as shareholders need to know. How many distribution channels for the product have been announced.... You may be invested here LB but simply put they are not performing given they have a gold class product. Truth hurts sometimes but it is still the truth.
ill be off too! not updating your shareholders isn't the best approach!
would love DB to go bang here you go.
not one update since what may?
I know I'm being a winger about GDR but on the back of a great presentation I went in heavy at £1.50 and since then 0 news and crap SP action.. I'll be honest I'm over exposed so a bit addicted to checking for RNS every morning.. missed another opportunity today as too much is tied in here...
I'll try and switch off for a bit, but one smidgen of promised news flow would help!
Marketing.. not sales.
Marketing is opening doors, sales is walking through the door and closing it behind you.
So very different.
But yes would love him to tap into ncyt sales team. They have capitalised on the opp.
The channel strategy is nothing new or innovative.
It comes down to the commision % they offer the partner and then how much it benefits their end user. Not the other way around.
I expect sales news this week, we are 7 weeks post ce mark.
Technik we do not yet have a poc device ready to market or have I missed something?
If NCYT had the product GDR has produced they would be shouting out to the world to buy their amazing product and getting sales in by now. I genuinely don't believe that GDR has the same levels of Sales experience and it has been a serious issue in GDR making progress. There is also no mention of distribution channels whereas NCYT clearly have the channels secured and AVCT even have channel with no product yet available. GDR fair play have produced a good product so we are told but it is starting to appear that they have little experience in actually selling to market... There Sales team either do your f job or DB get a new sales team in.
have AVCT or ODX got a lateral flow POC device yet? They'll have to go through exactly the same processes in terms of product registrations for approvals, etc. GDR much more advanced and sales will come as this is a product with a growing demand and a shortage of supply. GDR will partner sales channels, they don't seem to want to create in-house sales and all the additional costs that comes with in terms of product support. I personally think that's smart. Looking forward to the next steps here!
Sorry, should say they can't make all the sales in house.
Sales team..
They've got a singular commercial lead and the CEO.
I want to know their disti plan and how they educate and incentivize these partners.
They cant make the sales in house in my opinion
Spot on, teabiscuit. My sincere hope is that we don't have a classic bunch of scientific wizards who are useless at selling what they have. We will soon know.
FDA and WHO approvals are important for the company, yet the most important aspect is SALES, which we have been saying for a couple of weeks now. Top tier product and no early sales, says it all and the shareprice is currently correct. I want to see GDR release some good sales numbers but I am not holding my breath that we shall see any sales confirmations this week. GDR seem to be good for technical ability but hopeless when it comes to selling a product, sales team get the f on with it.
Yes I agree its significant but just as a precursor to sales. If you have not demonstrated the ability to sell a top tier product to Europe then I think the market respons to further approvals will be rather muted.
LB28 explain please ??
Yeh lol any movement would be nice at this point. Bit of progression is t too much to ask for
And btw I'm not talking 10s of millions in sales.
But if the product is as good as they are telling us.
Every sample sent should be followed with commercial discussions.
I'm expecting inroads in 4/5 territories.
Punter,
I hear what you're saying, but FDA approval is quite significant.
And LP, yes it may be a spike but its something at least.
I agree with Punter here. Approvals wont give us a sustained rise. Maybe spike on open but it is sales now needed.
They need to prove they can commercialize the offering. And soon.
"I hope we get it, but i think an approval would get us 20-25% on the SP, especially if its FDA."
Why? They have had CE marking for well over a month now and not demonstrated one single sale. Sales will drive the share price forwards, and sales alone imo.
If its a **** RNS this is what the rampers will say - He never said he would announce sales in July, it was only supposed to be a fiscal update.
Lp
I hope we get it, but i think an approval would get us 20-25% on the SP, especially if its FDA.